Biblio

Export 1310 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
A. Hatami, Monjazeb, S., and Glabe, C., The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils., J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
T. E. Golde, Schneider, L. S., and Koo, E. H., Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift., Neuron, vol. 69, no. 2, pp. 203-13, 2011.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study., J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
L. M. Giil, Vedeler, C. A., Kristoffersen, E. K., Nordrehaug, J. Erik, Heidecke, H., Dechend, R., Schulze-Forster, K., Muller, D. N., von Goetze, V. S., Cabral-Marques, O., Riemekasten, G., Vogelsang, P., Nygaard, S., Lund, A., and Aarsland, D., Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function., J Alzheimers Dis, vol. 59, no. 3, pp. 929-939, 2017.
E. C. K. Tan, Eriksdotter, M., Garcia-Ptacek, S., Fastbom, J., and Johnell, K., Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia., J Alzheimers Dis, vol. 65, no. 2, pp. 589-596, 2018.
A. Ivan B. Posis, Tarraf, W., Gonzalez, K. A., Soria-Lopez, J. A., Léger, G. C., Stickel, A. M., Daviglus, M. L., Lamar, M., Zeng, D., and González, H. M., Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging., J Alzheimers Dis, vol. 86, no. 1, pp. 53-65, 2022.
A. Ivan B. Posis, Tarraf, W., Gonzalez, K. A., Soria-Lopez, J. A., Léger, G. C., Stickel, A. M., Daviglus, M. L., Lamar, M., Zeng, D., and González, H. M., Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging., J Alzheimers Dis, vol. 86, no. 1, pp. 53-65, 2022.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
H. - C. Huang, Zheng, B. - W., Guo, Y., Zhao, J., Zhao, J. - Y., Ma, X. - W., and Jiang, Z. - F., Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose., J Alzheimers Dis, vol. 52, no. 3, pp. 899-911, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers., J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
H. Salem, Suchting, R., Gonzales, M. M., Seshadri, S., and Teixeira, A. L., Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis., J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging., Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
E. Werden, Khlif, M. Salah, Bird, L. J., Cumming, T., Bradshaw, J., Khan, W., Pase, M., Restrepo, C., Veldsman, M., Egorova, N., Patel, S. K., Gottlieb, E., and Brodtmann, A., APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke., J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review., J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review., J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features., J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features., J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
E. Grossi, Stoccoro, A., Tannorella, P., Migliore, L., and Coppedè, F., Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1517-22, 2016.
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study., J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
F. Jesus Martinez-Murcia, Górriz, J. Manuel, Ramírez, J., Segovia, F., Salas-Gonzalez, D., Castillo-Barnes, D., and Ortiz, A., Assessing Mild Cognitive Impairment Progression using a Spherical Brain Mapping of Magnetic Resonance Imaging., J Alzheimers Dis, vol. 65, no. 3, pp. 713-729, 2018.
S. Emrani, Libon, D. J., Lamar, M., Price, C. C., Jefferson, A. L., Gifford, K. A., Hohman, T. J., Nation, D. A., Delano-Wood, L., Jak, A., Bangen, K. J., Bondi, M. W., Brickman, A. M., Manly, J., Swenson, R., and Au, R., Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall., J Alzheimers Dis, vol. 61, no. 3, pp. 917-928, 2018.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline., J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
M. Mandecka, Budziszewska, M., Barczak, A., Pepłońska, B., Chodakowska-Żebrowska, M., Filipek-Gliszczyńska, A., Nesteruk, M., Styczyńska, M., Barcikowska, M., and Gabryelewicz, T., Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease., J Alzheimers Dis, vol. 54, no. 1, pp. 157-68, 2016.
M. Cabinio, Saresella, M., Piancone, F., LaRosa, F., Marventano, I., Guerini, F., Nemni, R., Baglio, F., and Clerici, M., Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 66, no. 3, pp. 1131-1144, 2018.

Pages